Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | tTF-NGR |
Synonyms | |
Therapy Description |
tTF-NGR is a fusion protein that comprises truncated tissue factor (tTF) linked to a C-terminal NGR peptide, which binds CD13 and potentially inhibits tumor vasculature and blood flow and reduces tumor growth (PMID: 32517329, PMID: 29110838). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
tTF-NGR | tTF-NGR is a fusion protein that comprises truncated tissue factor (tTF) linked to a C-terminal NGR peptide, which binds CD13 and potentially inhibits tumor vasculature and blood flow and reduces tumor growth (PMID: 32517329, PMID: 29110838). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|